MedTrace Logo

Bone Marrow Transplant Chart Review for RIC

NCT00723333 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2009-10-12

No results posted yet for this study

Summary

We will evaluate the records of 30 patients that have undergone allogeneic transplant, specifically looking at engraftment rate, relapse rate, disease free survival, overall survival, causes of death and other pertinent statistics. We will compare the outcomes to appropriate historical controls.

Conditions

Interventions

PROCEDURE

Reduced Intensity Conditioning (RIC) Allogenic Transplant

Reduced Intensity Conditioning (RIC) Regimen Allogenic Stem Cell Transplant

Sponsors & Collaborators

  • Fred Hutchinson Cancer Center

    collaborator OTHER

  • Baylor College of Medicine

    collaborator OTHER

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • University of Utah

    lead OTHER

Principal Investigators

  • Josef T Prchal, MD · University of Utah

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2009-07-31
Completion
2009-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00723333 on ClinicalTrials.gov